Literature DB >> 1995719

Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B.

M Waris1.   

Abstract

Time-resolved fluoroimmunoassay with monoclonal antibodies distinguishing between respiratory syncytial virus (RSV) group A and B strains was used to analyze their prevalence in Finland during 1981-1990 among 3285 patients with laboratory diagnosis of RSV, most of them hospitalized. The group typing of antigens in 608 RSV-positive nasopharyngeal aspirates showed a regular alternation of group prevalence, following the cyclic occurrence of the virus. Group A predominated in 73%-90% of specimens from 1981-1982, 1985-1986, and 1989-1990, whereas group B predominated in 70%-100% of specimens from 1983-1984 and 1987-1988. The epidemiologic occurrence of verified reinfections in hospitalized children and the group typing results indicated that children greater than 6 months of age during the first infection were more resistant to severe reinfection with the homologous than with the heterologous group of virus. The study shows that group antigenic variation of RSV has a significant effect on the epidemiology of the virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1995719     DOI: 10.1093/infdis/163.3.464

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  53 in total

1.  Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.

Authors:  T Heikkinen; H Valkonen; L Lehtonen; R Vainionpää; O Ruuskanen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.

Authors:  Paul D Scott; Rachel Ochola; Mwanajuma Ngama; Emelda A Okiro; D James Nokes; Graham F Medley; Patricia A Cane
Journal:  J Infect Dis       Date:  2005-11-17       Impact factor: 5.226

3.  Discharge Criteria for Bronchiolitis: An Unmet Need.

Authors:  Cristina Garcia-Mauriño; Melissa Moore-Clingenpeel; Rebecca Wallihan; Katalin Koranyi; Bavani Rajah; Tiffany Shirk; Maria Vegh; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2018-06       Impact factor: 2.129

4.  Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.

Authors:  W B Coggins; E J Lefkowitz; W M Sullender
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

5.  Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.

Authors:  Kalina T Zlateva; Philippe Lemey; Elien Moës; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 6.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 7.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.

Authors:  W M Sullender; L Sun; L J Anderson
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

9.  Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

Authors:  Janine Reiche; Brunhilde Schweiger
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

10.  Does the viral subtype influence the biennial cycle of respiratory syncytial virus?

Authors:  Gordana Mlinaric-Galinovic; Gordana Vojnovic; Jasna Cepin-Bogovic; Ana Bace; Jadranka Bozikov; Robert C Welliver; Ulrich Wahn; Ljiljana Cebalo
Journal:  Virol J       Date:  2009-09-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.